The U.S. Food and Drug Administration has placed a clinical hold on Intellia Therapeutics' two late-stage trials testing an ...
Clinical Trials Arena on MSNOpinion
The early phase advantage: the key to de-risking your clinical trials
Tamara Murdock, global head of early phase at Emerald Clinical Trials emphasises the importance for sponsors in choosing the ...
Eli Lilly and Company (LLY) on Wednesday said that its oral GLP-1 drug Orforglipron lowered blood glucose levels in two late-stage trials, confirming its potential in treating type-2 diabetes. While ...
While Carter continues to visit UAB for regular checkups, she has now been cancer-free for over three years. She uses her ...
Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was hospitalized with liver damage.
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. A positive readout of a Rapport Therapeutics seizure medicine in a ...
HONG KONG, Jun 15, 2022 - (ACN Newswire) - - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based ...
New interim data from a Phase III trial puts the company on track to file for FDA approval next year in an indication that ...
Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...
The initiative reflects the PPD business’ vision to promote sustainability throughout the clinical development ecosystem.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback